DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

TreAtments and outComes in paTients With prImary CutAneous Lymphoma

Recruiting

Conditions: Primary Cutaneous Lymphoma

First Posted Date: 2022-08-29

Last Posted Date: 2023-11-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 3000

Registration Number: NCT05518851

Locations: 🇨🇳
SUN YAI-SEN Memorial Hospital, SUN YAI-SEN University, Guandong, Guangdong, China
🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳
Hospital for Skin Disease, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, Jiangsu, China

and more 2 locations

Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients

Not Applicable

Recruiting

Conditions: Nerve Block
Dexmedetomidine
Pain, Postoperative
Chronic Pain
Prognosis
Mastectomy
Breast Neoplasms

Interventions: Procedure: Control group
Procedure: Erector spinae plane block

First Posted Date: 2022-08-10

Last Posted Date: 2023-11-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1206

Registration Number: NCT05494502

Locations: 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation

Recruiting

Conditions: Chronic Atrophic Gastritis

Interventions: Drug: MLD
Drug: WFC

First Posted Date: 2022-05-24

Last Posted Date: 2023-09-05

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 286

Registration Number: NCT05388890

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer

Not yet recruiting

Conditions: Carcinoma, Hepatocellular

First Posted Date: 2022-05-19

Last Posted Date: 2022-05-19

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 490

Registration Number: NCT05383066

Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection

Not Applicable

Recruiting

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Qingre Huashi Granules combined the modified dual therapy
Drug: Bismuth containing quadruple therapy

First Posted Date: 2022-05-06

Last Posted Date: 2022-10-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 160

Registration Number: NCT05364619

Locations: 🇨🇳
Peking University International Hospital, Beijing, Beijing, China
🇨🇳
Beijing Changping Integrative Medicine Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery

Not Applicable

Conditions: Neoplasms
Survival
Anesthesia, Inhalation
Aged
Surgical Procedure, Operative
Anesthesia, Intravenous

Interventions: Drug: Sevoflurane
Drug: Propofol

First Posted Date: 2022-04-25

Last Posted Date: 2022-05-02

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1228

Registration Number: NCT05343260

Locations: 🇨🇳
Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China
🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
Beijing Shijitan Hospital, Beijing, Beijing, China

and more 12 locations

Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

Not Applicable

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Bismuth-containing quadruple therapy
Drug: JWC containing quadruple therapy

First Posted Date: 2022-04-11

Last Posted Date: 2022-10-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 80

Registration Number: NCT05320133

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

Recruiting

Conditions: Atopic Dermatitis Eczema
Prurigo Nodularis

First Posted Date: 2022-04-07

Last Posted Date: 2024-08-15

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100000

Registration Number: NCT05316805

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

Novel Equation for Estimating Intraperitoneal Pressure

Completed

Conditions: Intraperitoneal Pressure
Peritoneal Dialysis
Equation

First Posted Date: 2022-04-06

Last Posted Date: 2022-04-06

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 200

Registration Number: NCT05313841

Locations: 🇨🇳
Jie Dong, Beijing, Beijing, China

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting

Conditions: Multiple Myeloma
Amyloidosis
Cryoglobulinemia
Castleman's Disease
Light Chain Deposition Disease
Heavy Chain Deposition Disease
Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes
Smoldering Multiple Myeloma
Plasma Cell Leukemia
Monoclonal Gammopathy of Undetermined Significance (MGUS)

First Posted Date: 2022-03-17

Last Posted Date: 2022-04-25

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 2000

Registration Number: NCT05283993

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy